These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 38854368)

  • 21. A Reliable Porcine Fascio-Cutaneous Flap Model for Vascularized Composite Allografts Bioengineering Studies.
    Pozzo V; Romano G; Goutard M; Lupon E; Tawa P; Acun A; Andrews AR; Taveau CB; Uygun BE; Randolph MA; Cetrulo CL; Lellouch AG
    J Vis Exp; 2022 Mar; (181):. PubMed ID: 35435906
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Limitations and limits and of vascularized composite allotransplantations: can we reach the holy grail?
    Grajek M; Bula D; Zeman M; Maciejewski A
    Curr Opin Organ Transplant; 2020 Dec; 25(6):609-614. PubMed ID: 33105202
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sensitization and Desensitization in Vascularized Composite Allotransplantation.
    Moris D; Cendales LC
    Front Immunol; 2021; 12():682180. PubMed ID: 34456906
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Partial Heterotopic Hindlimb Transplantation Model in Rats.
    Goutard M; Randolph MA; Taveau CB; Lupon E; Lantieri L; Uygun K; Cetrulo CL; Lellouch AG
    J Vis Exp; 2021 Jun; (172):. PubMed ID: 34180905
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Effects of Tacrolimus on Tissue-Specific, Protein-Level Inflammatory Networks in Vascularized Composite Allotransplantation.
    Aral AM; Zamora R; Barclay D; Yin J; El-Dehaibi F; Erbas VE; Dong L; Zhang Z; Sahin H; Gorantla VS; Vodovotz Y
    Front Immunol; 2021; 12():591154. PubMed ID: 34017323
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Psychosocial and bioethical challenges and developments for the future of vascularized composite allotransplantation: A scoping review and viewpoint of recent developments and clinical experiences in the field of vascularized composite allotransplantation.
    Kumnig M; Jowsey-Gregoire SG; Gordon EJ; Werner-Felmayer G
    Front Psychol; 2022; 13():1045144. PubMed ID: 36591015
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evolution and limitations of conventional autologous reconstruction of the head and neck.
    Pribaz JJ; Caterson EJ
    J Craniofac Surg; 2013 Jan; 24(1):99-107. PubMed ID: 23348264
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Defining chronic rejection in vascularized composite allotransplantation-The American Society of Reconstructive Transplantation and International Society of Vascularized Composite Allotransplantation chronic rejection working group: 2018 American Society of Reconstructive Transplantation meeting report and white paper Research goals in defining chronic rejection in vascularized composite allotransplantation.
    Kaufman CL; Kanitakis J; Weissenbacher A; Brandacher G; Mehra MR; Amer H; Zelger BG; Zelger B; Pomahac B; McDiarmid S; Cendales L; Morelon E
    SAGE Open Med; 2020; 8():2050312120940421. PubMed ID: 32704373
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The current status, evolution and future of facial reconstruction.
    Wallace CG; Wei FC
    Chang Gung Med J; 2008; 31(5):441-9. PubMed ID: 19097590
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diagnosing skin rejection in vascularized composite allotransplantation: advances and challenges.
    Sarhane KA; Khalifian S; Ibrahim Z; Cooney DS; Hautz T; Lee WP; Schneeberger S; Brandacher G
    Clin Transplant; 2014 Mar; 28(3):277-85. PubMed ID: 24476538
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adipose-derived stromal cell therapy combined with a short course nonmyeloablative conditioning promotes long-term graft tolerance in vascularized composite allotransplantation.
    Schweizer R; Taddeo A; Waldner M; Klein HJ; Fuchs N; Kamat P; Targosinski S; Barth AA; Drach MC; Gorantla VS; Cinelli P; Plock JA
    Am J Transplant; 2020 May; 20(5):1272-1284. PubMed ID: 31774619
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Premise and promise of mesenchymal stem cell-based therapies in clinical vascularized composite allotransplantation.
    Schweizer R; Gorantla VS; Plock JA
    Curr Opin Organ Transplant; 2015 Dec; 20(6):608-14. PubMed ID: 26536421
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Current status of vascularized composite tissue allotransplantation.
    Edtinger K; Yang X; Uehara H; Tullius SG
    Burns Trauma; 2014; 2(2):53-60. PubMed ID: 27602363
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Perioperative risk factors for vascularized composite allotransplantation: a systematic review and proposal of identity-defining VCA.
    Zhu H; Wei X; Lineaweaver W; Li Q
    Microsurgery; 2014 Mar; 34(3):240-4. PubMed ID: 23836513
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vascularized Composite Allotransplantation-An Emerging Concept for Burn Reconstruction.
    Ng ZY; Lellouch AG; Drijkoningen T; Chang IA; Sachs DH; Cetrulo CL
    J Burn Care Res; 2017; 38(6):371-378. PubMed ID: 28328655
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The need for inducing tolerance in vascularized composite allotransplantation.
    Ravindra KV; Xu H; Bozulic LD; Song DD; Ildstad ST
    Clin Dev Immunol; 2012; 2012():438078. PubMed ID: 23251216
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Engineering a Future with VCA: Applying Genetic Circuits to Engineer Tissues for Vascularized Composite Allotransplantation.
    Oliver JD; Duscher D; Hu MS
    J Plast Reconstr Aesthet Surg; 2021 Jan; 74(1):223-243. PubMed ID: 32499184
    [No Abstract]   [Full Text] [Related]  

  • 38. A novel rat full-thickness hemi-abdominal wall/hindlimb osteomyocutaneous combined flap: influence of allograft mass and vascularized bone marrow content on vascularized composite allograft survival.
    Ramirez AE; Cheng HY; Lao WW; Wang YL; Wen CJ; Wallace CG; Lin CF; Shih LY; Chuang SH; Wei FC
    Transpl Int; 2014 Sep; 27(9):977-86. PubMed ID: 24861714
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Engineering Vascularized Composite Allografts Using Natural Scaffolds: A Systematic Review.
    Lupon E; Lellouch AG; Acun A; Andrews AR; Oganesyan R; Goutard M; Taveau CB; Lantieri LA; Cetrulo CL; Uygun BE
    Tissue Eng Part B Rev; 2022 Jun; 28(3):677-693. PubMed ID: 34238047
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Costimulation Blockade in Vascularized Composite Allotransplantation.
    Giannis D; Moris D; Cendales LC
    Front Immunol; 2020; 11():544186. PubMed ID: 33042138
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.